J Korean Fract Soc.  2015 Jan;28(1):53-58. 10.12671/jkfs.2015.28.1.53.

Perioperative Blood Loss in Intramedullary Hip Screw for Intertrochanteric Fracture: Analysis of Risk Factors

• Park JH
• Jung HJ
• Shin HK
• Kim E
• Park SJ
• Ko TS
• Park JH

• KMID: 1774097
• DOI: http://doi.org/10.12671/jkfs.2015.28.1.53

Abstract

PURPOSE
We compared visible blood loss and calculated blood loss after intramedullary fixation in intertrochanteric fracture, and evaluated correlation between blood loss and its risk factors.
MATERIALS AND METHODS
A total of 256 patients who underwent closed reduction and intramedullary fixation in femoral intertrochanteric fracture between 2004 and 2013 were enrolled in this study. The total blood loss was calculated using the formula reported by Mercuiali and Brecher. We analyzed several factors, including fracture pattern (according to Evans classification), gender, age, body mass index (BMI), anesthesia method, cardiovascular and cerebrovascular disease, preoperative anemia, American Society of Anesthesiologists (ASA) score and use of antithrombotic agents.
RESULTS
Total calculated blood loss (2,100+/-1,632 ml) differed significantly from visible blood loss (564+/-319 ml). In addition, the blood loss of unstable fracture patient was 2,496+/-1,395 ml and multivariate analysis showed a significant relationship between blood loss and fracture pattern (p<0.01). However, other factors showed no statistically significant difference.
CONCLUSION
Total calculated blood loss was much greater than visible blood loss. Patients with unstable intertrochanteric fracture should be treated with care in order to reduce blood loss.

Keyword

Femur; Intertrochanteric fractures; Intramedullary nailing; Surgical blood loss; Risk factors

MeSH Terms

Anemia
Anesthesia
Blood Loss, Surgical
Body Mass Index
Femur
Fibrinolytic Agents
Fracture Fixation, Intramedullary
Hip Fractures
Hip*
Humans
Multivariate Analysis
Risk Factors*
Fibrinolytic Agents

Reference

1. Sehat KR, Evans RL, Newman JH. Hidden blood loss following hip and knee arthroplasty Correct management of blood loss should take hidden loss into account. J Bone Joint Surg Br. 2004; 86:561–565.

2. Good L, Peterson E, Lisander B. Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement. Br J Anaesth. 2003; 90:596–599.

3. Lemos MJ, Healy WL. Current concepts review: blood transfusion in orthopaedic operations. J Bone Joint Surg Am. 1996; 78:1260–1271.

4. Keating EM, Meding JB. Perioperative blood management practices in elective orthopaedic surgery. J Am Acad Orthop Surg. 2002; 10:393–400.

5. Lemaire R. Strategies for blood management in orthopaedic and trauma surgery. J Bone Joint Surg Br. 2008; 90:1128–1136.

6. Salido JA, Marín LA, Gómez LA, Zorrilla P, Martínez C. Preoperative hemoglobin levels and the need for transfusion after prosthetic hip and knee surgery: analysis of predictive factors. J Bone Joint Surg Am. 2002; 84:216–220.

7. Bell TH, Berta D, Ralley F, et al. Factors affecting perioperative blood loss and transfusion rates in primary total joint arthroplasty: a prospective analysis of 1642 patients. Can J Surg. 2009; 52:295–301.

8. Walker RW, Rosson JR, Bland JM. Blood loss during primary total hip arthroplasty: use of preoperative measurements to predict the need for transfusion. Ann R Coll Surg Engl. 1997; 79:438–440.

9. Rosencher N, Kerkkamp HE, Macheras G, et al. OSTHEO Investigation. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion. 2003; 43:459–469.

10. Slappendel R, Dirksen R, Weber EW, van der. An algorithm to reduce allogenic red blood cell transfusions for major orthopedic surgery. Acta Orthop Scand. 2003; 74:569–575.

11. Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am. 1999; 81:2–10.

12. Nam WD, Kim IY, Rhyu KH. Blood loss and transfusion in primary total hip arthroplasty. J Korean Hip Soc. 2006; 18:1–5.

13. Mylod AG Jr, France MP, Muser DE, Parsons JR. Perioperative blood loss associated with total knee arthroplasty. A comparison of procedures performed with and without cementing. J Bone Joint Surg Am. 1990; 72:1010–1012.

14. Sharrock NE, Salvati EA. Hypotensive epidural anesthesia for total hip arthroplasty: a review. Acta Orthop Scand. 1996; 67:91–107.

15. Juelsgaard P, Larsen UT, Sørensen JV, Madsen F, Søballe K. Hypotensive epidural anesthesia in total knee replacement without tourniquet: reduced blood loss and transfusion. Reg Anesth Pain Med. 2001; 26:105–110.

16. McLaughlin JR, Lee KR. The outcome of total hip replacement in obese and non-obese patients at 10- to 18-years. J Bone Joint Surg Br. 2006; 88:1286–1292.

17. Stickles B, Phillips L, Brox WT, Owens B, Lanzer WL. Defining the relationship between obesity and total joint arthroplasty. Obes Res. 2001; 9:219–223.

18. Chechik O, Thein R, Fichman G, Haim A, Tov TB, Steinberg EL. The effect of clopidogrel and aspirin on blood loss in hip fracture surgery. Injury. 2011; 42:1277–1282.

19. Foss NB, Kehlet H. Hidden blood loss after surgery for hip fracture. J Bone Joint Surg Br. 2006; 88:1053–1059.

20. Jensen JS. Classification of trochanteric fractures. Acta Orthop Scand. 1980; 51:803–810.

21. Dimon JH, Hughston JC. Unstable intertrochanteric fractures of the hip. J Bone Joint Surg Am. 1967; 49:440–450.